This grant, offered by the National Institutes of Health (NIH), is for establishing HIV-Associated Malignancy Research Centers (HAMRCs) through collaborative partnerships between U.S. and Low- and Middle-Income Country (LMIC) institutions. The primary purpose is to support research on HIV-associated cancers relevant to LMICs. Applicants are sought for Specialized Center Cooperative Agreements (U54), requiring at least one U.S. and two or more LMIC institutions per HAMRC. Each application must propose two to three research projects focusing on a single scientific theme related to HIV-associated malignancies, spanning basic, translational, population, or implementation studies, including mechanistic clinical trials. An Administrative Core and Developmental Core are mandatory components.
Opportunity ID: 337214
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-011 |
| Funding Opportunity Title: | U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 04, 2022 |
| Last Updated Date: | Jan 04, 2022 |
| Original Closing Date for Applications: | Mar 30, 2022 |
| Current Closing Date for Applications: | Mar 30, 2022 |
| Archive Date: | May 05, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Small businesses Private institutions of higher education County governments For profit organizations other than small businesses Independent school districts Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support research on human immunodeficiency virus (HIV)-associated cancers in low- and middle-income countries (LMICs) through the formation of collaborative partnerships between investigators in United States (U.S.) and investigators in LMICs. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for research on HIV-associated cancers from research institutions in the U.S. and LMICs. These partnerships are referred to as HIV-Associated Malignancy Research Centers (HAMRCs). Each proposed U54 HAMRC should be based upon partnerships involving at least one U.S. institution and institutions from at least two or more LMICs. Each HAMRC application is required to propose between two to three research projects that address questions in one scientific theme (e.g. viral-associated cancers) that is relevant to HIV-associated malignancies in LMICs or the U.S. The proposed projects may range, as appropriate, from basic research to translational efforts as well as to population and implementation studies. Mechanistic clinical studies that meet NIH’s definition of a clinical trial will be allowed. In addition, the proposed U54 HAMRC must include an Administrative Core and a Developmental Core. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-011.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 337214 Full Announcement-RFA-CA-22-011 -> RFA-CA-22-011-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271198 | Feb 28, 2022 | Mar 30, 2022 | View |
Package 1
Mandatory forms
337214 RR_SF424_5_0-5.0.pdf
337214 PHS398_CoverPageSupplement_5_0-5.0.pdf
337214 RR_OtherProjectInfo_1_4-1.4.pdf
337214 PerformanceSite_4_0-4.0.pdf
337214 RR_KeyPersonExpanded_4_0-4.0.pdf
337214 PHS398_ResearchPlan_4_0-4.0.pdf
337214 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337214 PHS_Additional_IndirectCosts_2_0-2.0.pdf
337214 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
